Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?

To: Apollo who wrote (11839)	12/3/1999 7:52:00 AM
From: Len	Respond to of 54805

I agree that Biotech will change the world. However, I got scortched about a year ago trying to figure out how to invest in these companies. IMHO, it is way too early even though a few are doing well. One wrong step and these companies are dead. Just think, future generations will live forever thanks to biotech. The earth will have a trillion people and humanity will be forced to canabalism because there won't be any place to grow food. Or, we will conquer space and they can all live in domes or wear space suits all the time. Can't wait for Biotech to improve life, eh?? Len

To: Apollo who wrote (11839)	12/3/1999 8:00:00 AM
From: Jill	Read Replies (1) \| Respond to of 54805

Stan, you phrased that very well about biotech...also, from what little I know, genes often work in concert, so there may not be as many eventual magic bullets as we'd hope. But, bp, it is indeed completely fascinating if an unstable & risky investing area at this point. For a while I was invested in Sepracor, which had a nice biotech story: they scooped up the patents to a lot of drugs, many of them biggies, and refined them to have less side effects and/or be more potent. This allowed major companies to partner with Sepracor to call the drug "new" when their patent expired and the generics came in, and thus hold onto market share. It seemed a great story, relying on known and successful drugs and it was a momentum play for a while; I haven't followed it lately, but even then the company was far slower and rockier than our gorillas in high tech, and was not expected to even turn a profit for several years. Jill

To: Apollo who wrote (11839)	12/3/1999 9:59:00 AM
From: MulhollandDrive	Read Replies (1) \| Respond to of 54805

Hi Stan, Thanks for you Bio Tech comments. I just popped in the office for a few minutes and have to leave shortly for an appointment. I did a quick check of some of genome Bio Techs (Hgsi, cra, mlnm) and all are up nicely this a.m... I'm thinking it might be worth the risk to pick a couple and just have a small portion of the portfolio dedicated to genome bio-tech stocks. It may ultimately put a little drag on the performance, but at the same time you'll have a stake if one of these guys hits the motherload<g> Talk to you later... bp